BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18386463)

  • 1. Results of postoperative radiotherapy in the treatment of uterine sarcomas: a retrospective analysis of 46 patients.
    Yalman D; Ozsaran Z; Baltalarli B; Demir O; Ozdemir N; Aras A
    Eur J Gynaecol Oncol; 2008; 29(1):46-51. PubMed ID: 18386463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
    Dusenbery KE; Potish RA; Argenta PA; Judson PL
    Am J Clin Oncol; 2005 Jun; 28(3):295-300. PubMed ID: 15923804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
    Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
    Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The retrospective analysis of patients with uterine sarcomas: A single-center experience.
    Terek MC; Akman L; Hursitoglu BS; Sanli UA; Ozsaran Z; Tekindal MA; Dikmen Y; Zekioglu O; Ozsaran AA
    J Cancer Res Ther; 2016; 12(1):309-13. PubMed ID: 27072256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus.
    Dusenbery KE; Potish RA; Judson P
    Gynecol Oncol; 2004 Jul; 94(1):191-6. PubMed ID: 15262141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative radiotherapy in endometrial carcinoma: analysis of prognostic factors in 440 cases.
    Yalman D; Ozsaran Z; Anacak Y; Celik OK; Ozkök S; Ozsaran A; Hanhan M; Haydaroğlu A
    Eur J Gynaecol Oncol; 2000; 21(3):311-5. PubMed ID: 10949404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of uterine sarcoma. A survey of 49 patients.
    Soumarová R; Horová H; Seneklová Z; Ruzicková J; Horová I; Budíková M; Slampa P; Kalábová R
    Arch Gynecol Obstet; 2002 Apr; 266(2):92-5. PubMed ID: 12049303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of adjuvant radiation in uterine sarcomas.
    Sampath S; Schultheiss TE; Ryu JK; Wong JY
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):728-34. PubMed ID: 19700247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uterine sarcoma in Tunisia: retrospective study about 14 cases].
    Bouzid N; Kanoun Belajouza S; Boussen H; Bouaouina N
    Gynecol Obstet Fertil; 2014 Dec; 42(12):838-43. PubMed ID: 25155830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group.
    Meurer M; Floquet A; Ray-Coquard I; Bertucci F; Auriche M; Cordoba A; Piperno-Neumann S; Salas S; Delannes M; Chevalier T; Italiano A; Blay JY; Mancini J; Pautier P; Duffaud F
    Int J Gynecol Cancer; 2019 May; 29(4):691-698. PubMed ID: 30772825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of radiotherapy on local control and survival in uterine sarcomas: a retrospective study from the Grup Oncologic Català-Occità.
    Ferrer F; Sabater S; Farrús B; Guedea F; Rovirosa A; Anglada L; Delannes M; Marín S; DuBois JB; Daly-Schveitzer N
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):47-52. PubMed ID: 10219793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
    Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
    Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant management of operated uterine sarcomas: A single institution experience.
    Cordoba A; Prades J; Basson L; Robin YM; Taïeb S; Narducci F; Hudry D; Bresson L; Chevalier A; Le Tinier F; Mirabel X; Lartigau É; Penel N; Leblanc É
    Cancer Radiother; 2019 Sep; 23(5):401-407. PubMed ID: 31351809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of radiotherapy treatment of uterine sarcoma.
    Sampath S; Gaffney DK
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):761-72. PubMed ID: 21783424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of patients with uterine sarcomas.
    Sharma DN; Rath GK; Kumar S; Kumar L; Bhatla N; Gandhi AK; Hariprasad R
    J Cancer Res Ther; 2011; 7(3):270-4. PubMed ID: 22044806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of adjuvant therapy in uterine sarcoma: experience of the Curie Institute].
    Deniaud-Alexandre E; Chauveinc L; de la Rochefordière A; Sastre X; Clough KB
    Cancer Radiother; 2001 Dec; 5(6):743-9. PubMed ID: 11797295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy in early stage uterine sarcomas: an open question.
    Gadducci A; Romanini A
    Eur J Gynaecol Oncol; 2001; 22(5):352-7. PubMed ID: 11766739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri.
    Knocke TH; Kucera H; Dörfler D; Pokrajac B; Pötter R
    Cancer; 1998 Nov; 83(9):1972-9. PubMed ID: 9806656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.